12th - 13th November 2018, Dublin, Ireland
On 12 & 13 November 2018, Dublin (Ireland) will host the BioTech Pharma Summit: Immunotherapy 2018 conference.
This year’s event will bring together established Pharma & Biotech thought-leaders, top academics and researchers, and a collection of emerging scientists exploring next-generation breakthroughs in the burgeoning area of cancer immunotherapy.
Immunotherapy 2018 will bring together the full community at a single meeting point to provide excitement and opportunity for the whole value chain.
Immunotherapy is the brightest hope and a cornerstone in the next generation fight against cancer. Novel discoveries in checkpoint inhibitors have enabled stunning breakthroughs and generated high optimism for the sector, including exciting new customizations in form of CAR -T and Oncolytic Viral Immunotherapy.
If you’re involved in the pharma, biotech, government, or academic sector looking toward commercialization and development of immunotherapies, this is an event you cannot afford to miss.
The BioTech Pharma Summit: Immunotherapy 2018 helps to address the gaps in knowledge of how and when to combine therapies, and how to integrate immunotherapy into current standard-of-care or novel targeted therapy approaches – both preclinical and clinical.
More details at: https://biotechpharmasummit.com/index.php/event/immunotherapy-2018/